They might be stuck. Its just that i find it difficult to posit a rationale for posting the new video and an article and the new website if they're truly stuck. It's not like they're a public company (like Replicel) and need to drum up investor money to move forward. Puretech ventures is a venture capital firm ....they have bags of money and can provide it to move things forward.
Total speculation here: but, my guess is that the CEO and other staff did not leave, they were let go by Puretech. The science of the concept is actually pretty straightforward. And really, based on Cot's talk/s, it's just a matter of them finding the right drug to combine with their wounding protocol. They have already managed to create "substantial hair" and "are moving forward", quoting (maybe paraphrasing) Bernat Olle, so they are having some success already. If their protocols are well worked out and easy to implement, then the whole project is easily outsourced. They just have to screen various drugs in their wounding assay, which any contract lab could perform for substantially cheaper than the cost of carrying a full scientific staff and research opertation. So why pay a CEO a huge salary/benefits etc.. along with the other staff when you and the technical advisors can manage the project yourself through outsourcing?
That's my hopeful speculation for the week. Most likely not the case, but, as someone who's about to step off the NW2 ledge and enter the brutality of NW3+ stages, i need something to pin my hopes on.
Total speculation here: but, my guess is that the CEO and other staff did not leave, they were let go by Puretech. The science of the concept is actually pretty straightforward. And really, based on Cot's talk/s, it's just a matter of them finding the right drug to combine with their wounding protocol. They have already managed to create "substantial hair" and "are moving forward", quoting (maybe paraphrasing) Bernat Olle, so they are having some success already. If their protocols are well worked out and easy to implement, then the whole project is easily outsourced. They just have to screen various drugs in their wounding assay, which any contract lab could perform for substantially cheaper than the cost of carrying a full scientific staff and research opertation. So why pay a CEO a huge salary/benefits etc.. along with the other staff when you and the technical advisors can manage the project yourself through outsourcing?
That's my hopeful speculation for the week. Most likely not the case, but, as someone who's about to step off the NW2 ledge and enter the brutality of NW3+ stages, i need something to pin my hopes on.
Comment